Legend Biotech (LEGN) Research & Development (2019 - 2025)

Legend Biotech has reported Research & Development for 7 years, with the latest figure at -$101.3 million in Q4 2025.

• For the quarter ending Q4 2025, Research & Development rose 2.97% year-over-year to -$101.3 million; the trailing twelve-month figure through Dec 2025 stood at -$414.7 million (changed 0.28% YoY), and the FY2025 full-year result was -$414.7 million, changed 0.29% from the prior year.
• Research & Development for Q4 2025 stood at -$101.3 million, up from -$113.1 million in the prior quarter.
• The five-year high for Research & Development was -$71072.0 in Q1 2021, with the low at -$113.1 million in Q3 2025.
• Historically, Research & Development has averaged -$84.1 million across 5 years, with a median of -$95.7 million in 2023.
• Annual changes were most pronounced in 2022 — Research & Development sank 114639.98% — and 2023, when it jumped 99.87%.
• Legend Biotech's Research & Development stood at -$86.5 million in 2021, then climbed by 6.64% to -$80.8 million in 2022, then jumped by 99.87% to -$105683.0 in 2023, then slumped by 98685.99% to -$104.4 million in 2024, then advanced by 2.97% to -$101.3 million in 2025.
• The last three Research & Development figures came in at -$101.3 million (Q4 2025), -$113.1 million (Q3 2025), and -$98.3 million (Q2 2025), per Business Quant data.